'IMAX Movie of Body' Allows Stanford Geneticist To Stop Diabetes In Its Tracks
sciencehabit writes "Michael Snyder has taken 'know thyself' to the next level. Over a 14-month period, the molecular geneticist analyzed his blood 20 different times to pluck out a wide variety of biochemical data depicting the status of his body's immune system, metabolism, and gene activity. In yesterday's issue of Cell (abstract), Snyder and a team of 40 other researchers present the results of this extraordinarily detailed look at his body, which they call an integrative personal omics profile (iPOP) because it combines cutting-edge scientific fields such as genomics (study of one's DNA), metabolomics (study of metabolism), and proteomics (study of proteins). Instead of seeing a snapshot of the body taken during the typical visit to a doctor's office, iPOP effectively offers an IMAX movie, which in Snyder's case had the added drama of charting his response to two viral infections and the emergence of type 2 diabetes."
Let me know when they can stop, and reverse, Type 1.
Really neat stuff until the part where the massive testing had nothing to do with his diabetes control. Oh, and I am sure the idea of more testing in a medical-cost-cutting world is going to go over really well.
Slashdot headlines are getting pathetically lame. This kind of twisted deceptive word play is what I expect when I stand in line at the grocery store. Would it have been stooping so low to integrity to post
'IMAX Movie of Body' Allows Stanford Geneticist To See Type 2 Diabetes Progress Like Never Before
?
One man's pink plane is another man's blue plane.
Cell is published by Elsevier which has been in the news recently because of a boycott. A search provides http://www.guardian.co.uk/science/2012/feb/02/academics-boycott-publisher-elsevier I support the boycott.
Constant monitoring could be the next big thing in medicine.
We currently diagnose based on discrete measurements compared with cutoffs - "averages" and numbers which are rounded to easily-remembered values. For example, Type-II diabetes is indicated when glucose is over 200mg/dl 2 hours after an oral glucose test. ...that seems like an awfully contrived number, simply because it's so easy to remember.
Instead of single point cutoff measurements, maybe we could get better diagnoses if we could see the change in values over time. Perhaps a more accurate diagnosis of diabetes would come from characterizing the slope of several months worth of glucose measurements.
With the rise of cheap microprocessors, I think there's a lot of opportunity for medical monitoring. Something like a wristwatch which records 10 types of measurements every hour. Of course I don't know how this could be done - perhaps spectroscopic measurements of reflected light through the skin, or terahertz wave reflections.
I've often wondered if it's possible to make a USB peripheral that records to a TI Chronos wristwatch for later display.
I bet there's lots of interesting features there just waiting to be discovered.
And yes, I know this comment will be subsequently down moderated for saying this. So be it.
Not really.
Whenever people on slashdot say their comment will be modded down for being unpopular opinion, it usually ends up being modded up due to the kneejerk reaction of people to not seem biased.
I know I'll be modded down for saying this, but it has to be said.
Enjoy your catch-22.
'IMAX Movie of Body' Allows Stanford Geneticist To See Type 2 Diabetes Progress Like Never Before
Stop with the IMAX. It's a stupid analogy (I know, not yours) and this is a tech site. Perhaps:
"Comprehensive time-series body data analysis sheds new light on Type 2 Diabetes Progression."
Next thing you know, they'll be changing the Big & Tall Section at the department store to the IMAX Clothing section. I wonder if attendance is down at real IMAX theatres since the brand's destruction.
My God, it's Full of Source!
OUTSIDE_IP=$(dig +short my.ip @outsideip.net)
I work in the publishing industry for a small publisher.
I was at a convention several weeks ago and spoke with some people who worked for a subsidiary of Elsevier. As an aside, just like in other industries, the publishing industry conglomerates are GIANT. Beyond the science and medical journals that were involved in starting the boycott, Elsevier owns LexisNexis (synonymous with law databases and also a book publisher), Harcourt (fiction), Butterworth, and many more. They have gobbled up literally dozens of formerly independent publishers, and in general data and knowledge companies in all fields.
Anyway, the employees of this particular subsidiary said Elsevier was SEVERELY hurting because of the boycott. I was shocked... I had assumed the boycott would have minimal impact. These particular employees (again, not of Elsevier directly) were glad as they were fully aware of how expensive Elsevier journals are and how ridiculous Elsevier's links in to government are. One of them said basically that Elsevier had spent millions of dollars over the past 15 years to get exclusive rights to public domain research (link). Once they got it, the situation blew up and Elsevier backed off--waiting no doubt for people to forget.
This also goes to show how many of the individuals in a corporation can believe the "right" thing but that horrible leadership at the top is all that matters.
It's corporations like Elsevier that give ALL companies a bad name. I support the boycott.
"eyelet transplantation" (ie, from a healthy donor, into a Type 1 Diabetes sufferer)
For the sake of helping any searchers not miss a load of references through searching on "eyelets" ....
These are "islets", not "eyelets", i.e. "Islets of Langerhans" (named for the scientist who first described them), they are little islands of special tissue in the pancreas gland, and they contain the beta-cells that normally make insulin, and in Type-1 diabetes they fail after attack by autoimmune processes. Their transplantation has been both promising and problematic, and as the parent post noted, tissue rejection problems have been met by immunosuppression.
-wb-